Lasa Supergenerics Ltd
Lasa Supergenerics Ltd (LASA) last traded at ₹6.82, a market capitalisation of ₹34.2 crore. Over the past 52 weeks the stock has ranged between ₹5.65 and ₹14.1. Lasa Supergenerics Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1.23 crore and net profit of ₹-3.58 crore. Figures are as of 25 Aug 2026 and are not real time.
Lasa Supergenerics Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Lasa Supergenerics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1.23 cr, down 93.9% from ₹20.01 cr a year earlier. Net profit was ₹-3.58 cr, up 83.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 39.39 | 33.08 | 39.14 | 20.01 | 3.06 | 2.2 | -0.13 | 1.23 |
| Expenses | 38.6 | 32.81 | 35.73 | 20.51 | 7.06 | 2.95 | 1.99 | 2.62 |
| Operating profit | 0.79 | 0.27 | 3.41 | -0.5 | -4 | -0.75 | -2.12 | -1.39 |
| OPM % | 2.01% | 0.82% | 8.71% | -2.50% | -130.72% | -34.09% | — | -113.01% |
| Other income | 1.95 | 8.91 | -21.52 | -20.44 | 0.01 | 0.02 | -0.42 | -0.38 |
| Interest | 1.24 | 0.47 | 0.11 | 0.03 | 0.12 | 0.11 | 0.13 | 0.14 |
| Depreciation | 2.81 | 2.8 | 3.9 | 1.57 | 1.57 | 1.57 | 1.31 | 1.57 |
| Profit before tax | -1.31 | 5.91 | -22.12 | -22.54 | -5.68 | -2.41 | -3.98 | -3.48 |
| Tax % | 146.56% | 7.11% | -35.40% | -6.30% | 10.04% | 5.81% | 4.77% | 3.16% |
| Net profit | -3.23 | 5.49 | -14.29 | -21.12 | -6.25 | -2.55 | -4.16 | -3.58 |
| EPS (₹) | -0.64 | 1.10 | -2.85 | -4.22 | -1.25 | -0.51 | -0.83 | -0.71 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Lasa Supergenerics Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 201 | 137 | 130 | 104 | 142 | 25 | 6 |
| Operating profit | 47 | 16 | -6 | 2 | 6 | -7 | -8 |
| OPM % | 24% | 12% | -4.9% | 2.1% | 4.4% | -29% | -130% |
| Net profit | 23 | -5 | -39 | -22 | -15 | -34 | -17 |
| EPS (₹) | 5.60 | -1.31 | -7.71 | -4.34 | -2.95 | -6.80 | -3.30 |
TTM is the trailing twelve months to the most recent quarter.
Lasa Supergenerics Ltd growth and returns
- 10 Years
- %
- 5 Years
- -34%
- 3 Years
- -42%
- TTM
- -95%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 10%
- TTM
- -547%
- 10 Years
- %
- 5 Years
- -38%
- 3 Years
- -35%
- 1 Year
- -21%
- 10 Years
- 1%
- 5 Years
- -8%
- 3 Years
- -10%
- Last Year
- -20%
Lasa Supergenerics Ltd shareholding pattern
Promoters held 53.65% at Mar 2026, broadly unchanged since Mar 2025. FIIs 0.00%.
| % held | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% |
| FIIs | 0.00% | 0.01% | 0.00% | 0.00% | 0.47% | 0.00% | 0.00% | 0.00% |
| Public | 46.34% | 46.32% | 46.35% | 46.35% | 45.88% | 46.35% | 46.34% | 46.35% |
| No. of shareholders | 27,217 | 27,968 | 27,272 | 27,188 | 28,115 | 28,656 | 28,120 | 27,702 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Lasa Supergenerics Ltd corporate filings
- Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026Company Updatelow impact
Cruxal's analysis: Lasa Supergenerics Limited has informed the stock exchanges that Mr. Ganesh Potdar has…
Read the full analysis - Integrated filing for Quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Lasa Supergenerics Ltd has submitted its integrated filing for the quarter ended June 30…
Read the full analysis - Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....Board Meetinghigh impact
Cruxal's analysis: Lasa Supergenerics Limited reported a net loss of 3.57 crore for the quarter ended June…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Lasa Supergenerics Ltd
Cruxal reads every Lasa Supergenerics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.